Skip to Content

Reunion Neuroscience Inc.

Merger

  • Date:
  • 6/6/2023
  • Company Name:
  • Reunion Neuroscience Inc.
  • Stock Symbol:
  • REUN
  • Company Name - Buyer:
  • MPM BioImpact
  • Status:
  • Investigating
  • Merger Announcement Date:
  • 6/1/2023

Case Finder

Locate any case using the tools below.

NEW YORK, June 6, 2023 – Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of Reunion Neuroscience Inc. (NASDAQ: REUN) (“Reunion”) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by MPM BioImpact (“MPM”).

On June 1, 2023, Reunion announced that it had entered into an agreement to be acquired by MPM in a $13.1 million all cash deal. Pursuant to the merger agreement, all holders of outstanding common shares of Reunion will be entitled to receive $1.12 in cash for each share held immediately prior to the effective time of the Arrangement. Based on the Bank of Canada daily exchange rate as of the close of business on May 31, 2023, this would be approximately $1.52 per Share in Canadian dollars, representing a premium of approximately 43.1% over the trailing 30-trading-day volume weighted average price. The deal is expected to close in the third quarter of 2023.

Bragar Eagel & Squire is concerned that Reunion's board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Reunion's stockholders.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Reunion Neuroscience Inc.. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: